Does Amberen work for menopause symptoms?

Our verdict: Limited evidence — real placebo-controlled trial data, but not yet independently replicated, and the published research discloses a financial tie to the manufacturer.

Amberen's original formula, a succinate-based dietary supplement, is one of the few menopause supplements on this site's list that has actual randomized, double-blind, placebo-controlled trial data behind it. That's genuinely notable — but it comes with an important caveat about who ran the research.

What the trials actually found

A pooled analysis combined data from two identical randomized, double-blind, placebo-controlled 90-day trials (114 women on the supplement, 113 on placebo, ages 42–60). Compared with placebo, the supplement group showed:

• Significant improvement in 16 of 21 menopausal symptoms measured on the Greene Climacteric Scale (p≤0.05)
• A significant reduction in anxiety (p<0.0001, State-Trait Anxiety Inventory)
• Significant reductions in weight, BMI, and waist/hip circumference
• A significant increase in serum estradiol versus baseline

That's a meaningfully positive, well-designed trial result.

The conflict of interest worth knowing about

Here's the caveat we think matters most: the published paper's own conflict-of-interest disclosure states that one of the four authors is a paid consultant for the manufacturer of the supplement being studied, and the other three authors were investigators on the trials — meaning none of the four authors were independent of the research they were reporting on.

This doesn't mean the results are false. Randomization, double-blinding, and placebo control are real safeguards against bias, and this trial used all three. But industry-sponsored and industry-linked research has a well-documented pattern of producing more favorable results than independent studies asking the same question — which is exactly why independent replication matters before a grade higher than Limited is warranted. We haven't found an independent, non-industry-linked trial of this product to point to yet.

One more thing worth flagging

Amberen's current product lineup has expanded well beyond the original formula tested in these trials — into separate products for libido, joint support ("Keep Agile"), focus, and more. The research discussed here is specific to the original succinate-based menopause formula; we haven't found trial data covering these newer, separate product lines, so this verdict doesn't extend to them.

What to consider

• Real placebo-controlled trial data exists for the original formula — a step up from most competitors on this list
• Industry ties mean independent replication is still needed before we'd grade this higher
• Newer product-line extensions (libido, joint, focus formulas) aren't covered by this research

Compare this verdict against Relizen and other hot flash options in our full does it work? evidence checker, which lets you filter by symptom and evidence grade.